TipRanks
Advertisement
Advertisement

GB:0HNC Stock Latest News

BioMarin Pharmaceutical Adds Independent Director to Board
Company AnnouncementsBioMarin Pharmaceutical Adds Independent Director to Board
3h ago
8K
BMRN
BioMarin names Robert Plenge, M.D., Ph.D., to board of directors
PremiumThe Fly
BioMarin names Robert Plenge, M.D., Ph.D., to board of directors
3h ago
BMY
BMRN
BioMarin: Neutral (Hold) Rating Reiterated as VOXZOGO Opportunity Balances YUVIWEL Competitive Risk; $60 Price Target Unchanged
PremiumRatings
BioMarin: Neutral (Hold) Rating Reiterated as VOXZOGO Opportunity Balances YUVIWEL Competitive Risk; $60 Price Target Unchanged
4d ago
BMRN
BioMarin reports new data from Phase 3 CANOPY-HCH-3 study
PremiumThe Fly
BioMarin reports new data from Phase 3 CANOPY-HCH-3 study
5d ago
BMRN
Ascendis Pharma price target raised to $312 from $304 at Oppenheimer
PremiumThe Fly
Ascendis Pharma price target raised to $312 from $304 at Oppenheimer
12d ago
ASND
BMRN
BioMarin Completes Acquisition of Dutch Biotech Alesta Therapeutics
PremiumCompany AnnouncementsBioMarin Completes Acquisition of Dutch Biotech Alesta Therapeutics
13d ago
8K
BMRN
BioMarin completes agreement to acquire Alesta Therapeutics
Premium
The Fly
BioMarin completes agreement to acquire Alesta Therapeutics
13d ago
BMRN
Balanced Upside and Execution Risks Lead Richter to Maintain Hold on BioMarin After ASND Settlement and Voxzogo Expansion Plans
Premium
Ratings
Balanced Upside and Execution Risks Lead Richter to Maintain Hold on BioMarin After ASND Settlement and Voxzogo Expansion Plans
13d ago
BMRN
BioMarin Settlement with Ascendis Clears Legal Overhang; Analyst Reaffirms Buy Rating and Maintains $114 Price Target
PremiumRatings
BioMarin Settlement with Ascendis Clears Legal Overhang; Analyst Reaffirms Buy Rating and Maintains $114 Price Target
13d ago
BMRN
BioMarin price target raised to $86 from $85 at Cantor Fitzgerald
PremiumThe Fly
BioMarin price target raised to $86 from $85 at Cantor Fitzgerald
13d ago
ASND
BMRN
Ascendis Pharma price target lowered to $273 from $275 at Morgan Stanley
PremiumThe Fly
Ascendis Pharma price target lowered to $273 from $275 at Morgan Stanley
13d ago
ASND
BMRN
BioMarin price target raised to $90 from $88 at Piper Sandler
PremiumThe Fly
BioMarin price target raised to $90 from $88 at Piper Sandler
13d ago
ASND
BMRN
BioMarin Kept at Hold as YUVIWEL Royalties Lift DCF and Price Target Rises from $59 to $60 Amid VOXZOGO Headwinds
PremiumRatingsBioMarin Kept at Hold as YUVIWEL Royalties Lift DCF and Price Target Rises from $59 to $60 Amid VOXZOGO Headwinds
14d ago
BMRN
Analyst Sees BioMarin Undervalued After Ascendis Settlement, Modestly Raising Price Target to $105
Premium
Ratings
Analyst Sees BioMarin Undervalued After Ascendis Settlement, Modestly Raising Price Target to $105
14d ago
BMRN
H.C. Wainwright trims Ascendis target, says litigation overhang removed
Premium
The Fly
H.C. Wainwright trims Ascendis target, says litigation overhang removed
14d ago
ASND
BMRN
BioMarin price target raised to $105 from $104 at Jefferies
PremiumThe Fly
BioMarin price target raised to $105 from $104 at Jefferies
14d ago
ASND
BMRN
BioMarin price target raised to $60 from $59 at H.C. Wainwright
PremiumThe Fly
BioMarin price target raised to $60 from $59 at H.C. Wainwright
14d ago
ASND
BMRN
BioMarin price target raised to $109 from $105 at Raymond James
PremiumThe Fly
BioMarin price target raised to $109 from $105 at Raymond James
14d ago
ASND
BMRN
Ascendis Pharma price target lowered to $304 from $306 at BofA
PremiumThe Fly
Ascendis Pharma price target lowered to $304 from $306 at BofA
14d ago
ASND
BMRN
Ascendis Pharma price target lowered to $330 from $333 at Jefferies
PremiumThe FlyAscendis Pharma price target lowered to $330 from $333 at Jefferies
14d ago
ASND
BMRN
Ascendis Pharma price target lowered to $326 from $328 at Stifel
Premium
The Fly
Ascendis Pharma price target lowered to $326 from $328 at Stifel
14d ago
ASND
BMRN
BioMarin Pharmaceutical Secures Global CNP Licensing Settlement
Premium
Company Announcements
BioMarin Pharmaceutical Secures Global CNP Licensing Settlement
14d ago
8K
BMRN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >